A Phase 2 Multi-Center, Open Label Long-Term Extension Trial To Assess The Safety Of Oral Uk-390,957 Administered As Required In Adult Men With Premature Ejaculation
A Phase 2 Multi-Center, Open Label Long-Term Extension Trial To Assess The Safety Of Oral Uk-390,957 Administered As Required In Adult Men With Premature Ejaculation
To determine whether UK-390,957 is a safe treatment for premature ejaculation.
Inclusion Criteria:
Exclusion Criteria:
Vorhees, New Jersey, United States
Milwuakee, Wisconsin, United States
Montréal, Quebec, Canada
Balcali, Adana, Turkey (Türkiye)
Nr Lichfield, Staffordshire, United Kingdom
Devon, United Kingdom